Beta

Spending
Congress
Stocks
Lobbying

Spending
Congress
Stocks
Lobbying

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Congress
Stocks
Lobbying

GENMAB US, INC. — Lobbying — Receipts Report

LD-2 disclosure · 1st Quarter - Report (No Activity)

GENMAB US, INC.

via BALLARD PARTNERS

1st Quarter (Jan 1 - Mar 31) · 2026Posted Apr 15, 2026Filing document ↗LDA record ↗

Income$60Kfee reported

Client

Name: GENMAB US, INC.
Description: Biotechnology company
Location: New Jersey · United States of America

Registrant

Firm: BALLARD PARTNERS
Description: Government relations and advocacy services
Location: Washington, District of Columbia, United States of America

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.